Home › Drug Use and Addiction › Minnesota › Minneapolis
Drug Use and Addiction clinical trials in Minneapolis, MN
4 studies for Drug Use and Addiction are looking for participants at sites in and around Minneapolis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Project REACH: A Comprehensive Telehealth Intervention at Syringe Service Programs to Engage People Who Use Drugs
RecruitingHealthy volunteers welcome
- University of Minnesota, Minneapolis
Personalized Approach to Healthy Use and Recovery (PATH) Trial
Recruiting
- Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis
Combining a Smartphone App With Medications to Manage Heavy Drinking
Recruiting
- Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis
Brain Training for Substance Use Disorders
RecruitingHealthy volunteers welcome
- University of Minnesota - Department of Psychiatry & Behavioral Health, Minneapolis
About Drug Use and Addiction
Drugs include prescription and over-the-counter medicines, alcohol, tobacco, and illegal substances. Repeated drug use can change the brain and lead to addiction.
More about Drug Use and Addiction on MedlinePlus
Drug Use and Addiction trials in other cities
- Baltimore, MD13 studies
- New York City, NY9 studies
- Houston, TX9 studies
- New Haven, CT8 studies
- Charleston, SC8 studies
- Boston, MA7 studies
- Chicago, IL7 studies
- San Francisco, CA6 studies
- San Diego, CA6 studies
- Los Angeles, CA6 studies
- Dallas, TX5 studies
- Providence, RI5 studies
Other studies in Minneapolis
- Non-Small Cell Lung Cancer27 studies
- Breast Cancer27 studies
- Ovarian Cancer24 studies
- Prostate Cancer23 studies
- Cancer (all types)22 studies
- Heart Failure21 studies
- Acute Myeloid Leukemia20 studies
- Lung Cancer20 studies
- Colorectal Cancer19 studies
- Endometrial Cancer18 studies
- Parkinson's Disease17 studies
- Cardiovascular Disease15 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.